# Radiopharm (RADX) — News

RADX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/radx/news

## Recent headlines

- [Trading halted: (RADX) Due to limit-up limit-down trading pause](https://www.ainvest.com/news/trading-halted-radx-due-limit-limit-trading-pause-2610) — AInvest Wire, Oct 5, 2026
  Trading in shares of RADX has been temporarily suspended due to a limit-up limit-down trading pause, a mechanism designed to stabilize markets during periods of extreme volatility. This halt prevents further trading until market conditions stabilize and ensures orderly price discovery. Such pauses…
- [Radiopharm Theranostics Ltd-RAD completes meeting with US FDA for development of RAD101](https://www.ainvest.com/news/radiopharm-theranostics-rad-completes-meeting-fda-development-rad101-2610) — AInvest Wire, Oct 4, 2026
  Radiopharm Theranostics Ltd (ASX: RAD, NASDAQ: RADX) has completed an End-of-Phase 2 (EOP2) meeting with the U.S. Food and Drug Administration (FDA) regarding the development of its imaging agent RAD101 for the diagnosis of recurrent brain metastases. The meeting, scheduled for October 1, 2026,…
- [Chimeric Therapeutics - Phillip Hains appointed interim chairman](https://www.ainvest.com/news/chimeric-therapeutics-phillip-hains-appointed-interim-chairman-2610) — AInvest Wire, Oct 1, 2026
  Chimeric Therapeutics Limited (ASX: CHM) has announced Phillip Hains as interim chairman , effective immediately. This decision follows a strategic review of the company’s governance structure and aims to provide leadership during a critical phase of its development. Phillip Hains brings extensive…
- [Radiopharm Theranostics - Significant tumor uptake observed in all evaluable pancreatic cancer patients](https://www.ainvest.com/news/radiopharm-theranostics-significant-tumor-uptake-observed-evaluable-pancreatic-cancer-patients-2609) — AInvest Wire, Sep 9, 2026
  Radiopharm Theranostics has reported significant tumor uptake of its PARP-targeted theranostic radiopharmaceutical in preclinical studies involving pancreatic cancer models. The compound, DOTA-PEG-PARPi, demonstrated strong affinity and retention in tumor tissues, with peak uptake observed three…
- [Radiopharm Theranostics - Positive safety and favorable biodistribution observed in all subjects dosed with rad301](https://www.ainvest.com/news/radiopharm-theranostics-positive-safety-favorable-biodistribution-observed-subjects-dosed-rad301-2609) — AInvest Wire, Sep 9, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).